“Superlative transactional IP work, especially in cutting-edge technologies, such as blockchain, medical technology and machine learning“ IAM MAGAZINE 2019
July 15, 2020>>
Horn & Co. represented Pontifax’s Venture Lending Fund in a $30M Convertible Debt Financing Agreement with ProQR Therapeutics N.V
June 14, 2020>>
Proud to be ranked, again, by IAM Magazine as one of top 4“highly recommended” Israeli firms in intellectual property transactions
May 13, 2020>>
Vascular Biogenics Ltd. raises an additional $8.1 million, completing an aggregate $18.1 million raise. Yuval Horn, Keren Kanir and Shimrit Roznek represented VBL in this transaction.
May 4, 2020>>
Horn & Co. has been recognized by Legal 500 as a “Tier 1” firm in Israel in the field of Healthcare and Life Sciences
March 30, 2020>>
Proud of our client, Diagnostic Robotics Ltd. that developed a system for detecting COVID-19
February 20, 2020>>
Yuval Horn noted once again as a Thought Leader Global Elite 2020 in Life Sciences by Who’s Who Legal, the only individual from Israel.
January 20, 2020>>
“They were providing services to one of the more innovative projects coming out of Israel in blockchain and trying to secure SEC approval for a project, which is very difficult to get.”
December 18, 2019>>
Paz Abercohen, Yuval Horn and Yonatan Levinstein of Horn & Co. represented Raziel Therapeutics in its $22 million series C round, led by Pontifax, with participation from existing investors as well as new investors, Catalyst Fund, Quark venture, Peregrine Investments and Wille AG.
October 10, 2019>>
Yuval Horn will moderate a panel about AI and eHealth disruption in the medical and lifestyle markets with Markus von Fuchs at the upcoming IBA 6th Biennial Technology Law Conference in Berlin.